Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis